Thyroid

Latest News

Annual Postoperative Ultrasound May Not Be Necessary in Low-Risk Thyroid Cancer

By

Hannah Dellabella

Serum tumor markers alone can provide reliable surveillance of patients who undergo total thyroidectomy for low- and intermediate-risk papillary thyroid carcinoma.

Entractinib, a Tumor Agnostic Therapy, Receives FDA Approval

By

Brian Park, PharmD

Rozlytrek is a kinase inhibitor that selectively targets ROS1 and NTRK fusions.

Estimates of Abnormal TSH Levels in Youth Hospitalized for Psychiatric Care

About 6 percent of psychiatrically hospitalized youth have abnormal thyroid-stimulating hormone measures.

No Difference in Levothyroxine Dose in Patients With vs Without Heart Failure

By

Amit Akirov, MD

Maintenance dose of levothyroxine does not differ in patients with hypothyroidism with vs without heart failure.

Thyroid Dysfunction Common in Children Treated With Amiodarone

By

Hannah Dellabella

Children and young adults treated with amiodarone have a significant likelihood for thyroid dysfunction soon after treatment initiation.

Case Report: Severe Proximal Myopathy Can Be Secondary to Hypothyroidism, Hashimoto Thyroiditis

By

Emily Pond

This case study illustrates that severe proximal myopathy can be secondary to hypothyroidism. It also emphasizes the importance of measuring thyroid function in patients with proximal weakness, myalgia, and a significantly raised creatine kinase.

Patient Preference for Levo-Triiodothyronine, Levothyroxine Combination Therapy vs Levothyroxine Alone

By

Amit Akirov, MD

Researchers assessed patient preference for combination L-T3/L-T4 treatment vs L-T4 monotherapy.

Thyroid-Stimulating Hormone Reference Ranges for Extremely and Very Preterm Infants

By

Amit Akirov, MD

At 3 to 4 weeks of life, when repeat newborn screening is often performed, median TSH levels ranged from 2.5 to 2.6 µIU/mL in both extremely and very preterm infants.

Maternal Thyroid Function in Early Pregnancy Affects Child Brain Morphology

By

Amit Akirov, MD

The association of TSH with child brain morphology differed according to gestational age at evaluation of thyroid function.

Many Patients Perceive Lack of Choice in Receiving RAI for Thyroid Cancer

Many patients diagnosed with differentiated thyroid cancer perceive that they have no choice about receiving radioactive iodine.

Teprotumumab BLA Submitted for Active Thyroid Eye Disease

By

Brian Park, PharmD

Teprotumumab is an investigational fully human monoclonal antibody that works by inhibiting the insulin-like growth factor 1 receptor.